Integrative Proteomics in Multifactorial Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 326
Special Issue Editor
Special Issue Information
Dear Colleagues,
Mass spectrometry-based proteomics is a crucial technology for advancing our understanding of biology and diseases. Recent breakthroughs made in proteomic technologies have allowed researchers to explore uncharted research areas, including post-translational modifications, interactomes, circulating proteomes, and immunopeptidomes. In addition, the integrative analysis of proteomics data with other omics data such as genomics, transcriptomics, and metabolomics is rapidly becoming a novel strategy used to achieve the next level of discoveries in biomarkers, therapeutic targets, drug targets, and the development of sensors. This Special Issue will collect studies related to the recent development of proteomic methods and their applications to research related to multifactorial diseases such as cancers, neurodegenerative diseases, and metabolic diseases, focusing on how proteomics and integrative multi-omics characterize the pathophysiology of diseases and help us to discover biomarkers, therapeutic targets, and sensor platforms.
Dr. Min-Sik Kim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mass spectrometry
- proteomics
- immunopeptidome
- post-translational modification
- multi-omics
- systems biology
- sensors
- precision medicine
